A 26-year-old woman with no prior history of acne presents with a 4-week history of an explosive eruption of large, coalescing inflammatory nodules, pustules, and draining sinuses on a violaceous-erythematous background confined to the central face (cheeks, chin, forehead, nose). She reports recent emotional stress and recent discontinuation of oral contraceptive pills. Examination reveals absence of comedones, and the trunk and periorbital areas are completely spared. The condition marked **B** in the diagram is suspected. Which of the following is the MOST APPROPRIATE initial management approach for this condition?
A. Oral isotretinoin monotherapy at 1 mg/kg/day initiated immediately for cumulative dose of 120–150 mg/kg
B. Oral prednisolone 0.5–1 mg/kg/day for 1–2 weeks, with overlapping oral isotretinoin started at low dose once inflammation subsides, tapered over 4–6 weeks
C. Oral minocycline 100 mg twice daily with topical retinoids for 6 weeks, followed by reassessment
D. Topical benzoyl peroxide and oral doxycycline 100 mg twice daily for 8–12 weeks without systemic corticosteroids
Explanation
Why option 1 is correct
The condition marked B (pyoderma faciale/rosacea fulminans) is a severe, abrupt-onset inflammatory dermatosis of the face in young adult women, characterized by absence of comedones, facial restriction with truncal sparing, and rapid progression over weeks. The gold-standard management requires PROMPT, AGGRESSIVE dual therapy: oral prednisolone 0.5–1 mg/kg/day for 1–2 weeks to rapidly suppress inflammation and prevent permanent scarring, with overlapping oral isotretinoin started at low dose (0.2–0.5 mg/kg/day) once inflammation subsides, then gradually titrated to cumulative dose of 120–150 mg/kg over 4–6 months. This combination prevents relapse and achieves durable remission. The corticosteroid is essential in the acute phase to control the explosive inflammation; isotretinoin alone is insufficient and delayed initiation risks irreversible scarring (Bolognia Dermatology 5e; Plewig Acne and Rosacea 4e).
Why each distractor is wrong
Option 2: Oral isotretinoin monotherapy initiated immediately at high dose (1 mg/kg/day) omits the critical acute-phase corticosteroid therapy. Isotretinoin alone cannot control the explosive inflammation rapidly enough to prevent permanent scarring in the first 1–2 weeks, and the dose is higher than the recommended low-dose initiation protocol for pyoderma faciale.
Option 3: Topical benzoyl peroxide and oral doxycycline monotherapy are insufficient for pyoderma faciale. This regimen is appropriate for mild-to-moderate acne vulgaris but lacks the systemic corticosteroid and isotretinoin required for aggressive control of this severe, rapidly progressive condition. Doxycycline alone will not prevent scarring.
Option 4: Oral minocycline with topical retinoids is a standard acne vulgaris regimen and is too conservative for pyoderma faciale. It omits both systemic corticosteroids and isotretinoin, and the 6-week timeline is insufficient for this rapidly progressive condition, which can cause permanent scarring within weeks if not aggressively treated.
High-YieldNEET PG
Pyoderma faciale = explosive facial eruption in young women + NO comedones + facial restriction + abrupt onset → requires DUAL therapy: oral prednisolone (acute control) + overlapping oral isotretinoin (durable remission) to prevent permanent scarring.
Bolognia Dermatology 5e; Plewig Acne and Rosacea 4e
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
